Algen Biotechnologies
Using CRISPR to find treatments for cancer and inflammation
Algen is using CRISPR to uncover disease-driving RNA messages to find treatments for cancer, inflammation and diseases with high unmet needs. We are harnessing the power of CRISPR gene-modulation and frontier AI to find drugs that modulate RNA messages at single-cell resolution. Algen's founders are bioengineer from Jennifer Doudna Lab and biotech commercialization expert, teamed up with experienced pharmaceutical executives.
- Website
- algenbio.com
- City
- San Francisco
- Country
- United States
- YC batch
- Winter 2020
- Team
- 17 people
- Stage
- Early stage
- AI-native
- Yes
More Health & bio in San Francisco
Innovaccer$1.3bn
Indian digital healthcare company.
Thatch$1bn
Health benefits. Valued at $1bn (September 2026).
Chan Zuckerberg BiohubLab
Nonprofit research network building virtual cell models.
AthelasHiring
Extensible, Integrated Technology that Simplifies Health Systems
ClipboardHiring
Every shift, Covered.
Benchling
Unlocking the power of biotech with modern software for modern science
Claim this profile
Free and instant: prove you run algenbio.com and edit the profile yourself.
- Your logo, office address and founder photos
- The ✓ Verified mark next to Algen Biotechnologies across the site
- Open roles listed on the Hiring board
- A followed link back to your website
A rank card with Algen Biotechnologies's standing on Labspie, or a simple badge. Both link to this profile and update themselves.
